luzindole has been researched along with ketanserin in 3 studies
| Studies (luzindole) | Trials (luzindole) | Recent Studies (post-2010) (luzindole) | Studies (ketanserin) | Trials (ketanserin) | Recent Studies (post-2010) (ketanserin) |
|---|---|---|---|---|---|
| 265 | 1 | 119 | 3,094 | 335 | 283 |
| Protein | Taxonomy | luzindole (IC50) | ketanserin (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0016 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.0021 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.015 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.015 | |
| 5-hydroxytryptamine receptor 1D | Homo sapiens (human) | 0.265 | |
| 5-hydroxytryptamine receptor 1B | Homo sapiens (human) | 6.5 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0184 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0027 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.0016 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.29 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.015 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 1.8 | |
| Synaptic vesicular amine transporter | Homo sapiens (human) | 0.18 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrios, VE; Duckles, SP; Krause, DN | 1 |
| Duckles, SP; Geary, GG; Krause, DN | 1 |
| Bonior, J; Goralska, M; Jastrzebska, M; Jaworek, J; Leja-Szpak, A; Link-Lenczowski, P; Nawrot-Porabka, K; Pierzchalski, P | 1 |
3 other study(ies) available for luzindole and ketanserin
| Article | Year |
|---|---|
Melatonin receptors mediate potentiation of contractile responses to adrenergic nerve stimulation in rat caudal artery.
Topics: Animals; Arteries; Electric Stimulation; In Vitro Techniques; Isometric Contraction; Ketanserin; Male; Melatonin; Muscle Contraction; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, Melatonin; Regional Blood Flow; Serotonin; Sympathetic Nervous System; Tail; Tryptamines; Vasoconstriction | 1995 |
Melatonin directly constricts rat cerebral arteries through modulation of potassium channels.
Topics: Animals; Apamin; Benzimidazoles; Cerebral Arteries; Charybdotoxin; GTP-Binding Proteins; Ketanserin; Male; Melatonin; Muscle Contraction; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Pertussis Toxin; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin; Tetraethylammonium; Tetraethylammonium Compounds; Tryptamines; Vasoconstriction; Virulence Factors, Bordetella | 1997 |
Kynuramines induce overexpression of heat shock proteins in pancreatic cancer cells via 5-hydroxytryptamine and MT1/MT2 receptors.
Topics: Cell Line, Tumor; Heat-Shock Proteins; Humans; Ketanserin; Kynuramine; Melatonin; Pancreatic Neoplasms; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Serotonin; Tropanes; Tryptamines; Tryptophan | 2015 |